Suppr超能文献

[400例慢性肾小球肾炎患者免疫抑制治疗的结果]

[Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].

作者信息

Müller V, Natusch R, Göbel U, Laske H R, Sperschneider H, Pap I, Sinn W, Koall W, Achenbach H, Tredt H J

出版信息

Z Urol Nephrol. 1985 Jan;78(1):39-55.

PMID:3976309
Abstract

For the judgment of the success of the immunosuppressive therapy of chronic glomerulonephritis 400 patients (242 males and 158 females) at an average age of 31.2 years were examined after an average duration of treatment of 31.9 months. Apart from the renal function (serum creatinine), the histological and immunohistological form of the glomerulonephritis for the valuation further clinico-paraclinical data were taken into consideration: proteinuria, nephrotic syndrome, arterial hypertension and the combination of nephrotic syndrome and arterial hypertension. At the beginning of the treatment 293 of 400 patients (73.2%) had a normal renal function, 107 of 400 patients (26.8%) were initially renal-insufficient. 16 of 400 patients (4.0%) had additionally a pyelonephritis and 12 of 400 patients (3.0%) had a lupus nephritis. 27 of 400 patients (6.9%) developed a terminal renal insufficiency after an average duration of observation of 40.5 months. Complications caused by therapy were registered in 104 of 400 patients (26.0%). Recommendations for the present therapy of chronic glomerulonephritis are formulated.

摘要

为了评判慢性肾小球肾炎免疫抑制疗法的成效,对400例患者(男性242例,女性158例)进行了检查,平均年龄31.2岁,平均治疗时长31.9个月。除肾功能(血清肌酐)外,为评估肾小球肾炎的组织学和免疫组织学形式,还考虑了其他临床旁临床数据:蛋白尿、肾病综合征、动脉高血压以及肾病综合征与动脉高血压的组合。治疗开始时,400例患者中有293例(73.2%)肾功能正常,400例患者中有107例(26.8%)最初存在肾功能不全。400例患者中有16例(4.0%)合并肾盂肾炎,400例患者中有12例(3.0%)患有狼疮性肾炎。400例患者中有27例(6.9%)在平均观察40.5个月后发展为终末期肾功能不全。400例患者中有104例(26.0%)记录到治疗引起的并发症。制定了关于目前慢性肾小球肾炎治疗的建议。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验